GlassScriptPhysician profile
Michael C Cusick
NPI 1043483134
$210,039.50
in general payments reported to CMS, 2019-2025
30 companies · $40K in 2025
The $40K reported for 2025 was more than what 87% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $4,397 · 2021: $18K · 2022: $36K · 2023: $28K · 2024: $71K · 2025: $40K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $105K · Travel and Lodging: $25K · Food and Beverage: $8,396 · Education: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $105,043.25 |
| Travel and Lodging | $25,405.03 |
| Food and Beverage | $8,395.92 |
| Education | $160.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $105,843.67 | 2019-2025 | Djo Surgical |
| Medacta USA, INC. | $46,606.64 | 2022-2025 | Primary Shoulder, Mecta, Reverse Shoulder |
| Exactech, INC. | $20,779.45 | 2019-2023 | |
| Stryker Corporation | $20,078.55 | 2019-2025 | Blueprint Patient Specific Instrumentation, Mako, Alphavent |
| Medinc of Texas | $4,001.91 | 2021-2025 | |
| Cipla USA INC. | $3,858.38 | 2019 | |
| Smith+Nephew, INC. | $2,372.99 | 2019-2024 | Mini-Open Latarjet, Bioinductive Implant With Arthroscopic Delivery System - Medium, Healicoil |
| Arthrex, INC. | $1,622.10 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $981.07 | 2019-2021 | |
| Depuy Synthes Sales INC. | $614.02 | 2021-2025 | Fibergraft Bg Morsels, Dynacord, Vivigen Mis Delivery System |
| Wright Medical Technology, INC. | $518.34 | 2019-2020 | |
| Innovation Technologies INC | $472.40 | 2020-2025 | Irrisept |
| Xiros INC | $331.03 | 2022 | |
| Integrity Orthopaedics, INC. | $284.22 | 2025 | Integrity Orthopaedics |
| Insight Medical Systems, INC. | $212.50 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biedermann Motech, INC. | $199.37 | 2019-2021 | |
| Miach Orthopaedics, INC. | $192.43 | 2025 | |
| Horizon Therapeutics Plc | $170.95 | 2019 | |
| Fx Shoulder Solutions, INC | $132.68 | 2021 | |
| Wound Management Technologies, INC | $130.98 | 2019 | |
| Skeletal Dynamics INC | $127.84 | 2024 | Ijs, Implate, Geminus |
| Eagle Pharmaceuticals, INC. | $124.98 | 2023 | |
| Catalyst Orthoscience | $105.28 | 2019-2022 | |
| Medical Device Business Services, INC. | $68.00 | 2021 | |
| Bone Support INC. | $55.20 | 2021 | |
| Arthrosurface Incorporated | $53.42 | 2019 | |
| Anika Therapeutics, INC. | $44.19 | 2022 | |
| Kci USA, INC. | $28.71 | 2021 | |
| Checkpoint Surgical, INC | $28.20 | 2025 | Checkpoint Stimulators |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cusick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.